Topline
As GLP-1 agonists like tirzepatide and semaglutide gain popularity among patients of childbearing age, concerns have emerged over reduced contraceptive efficacy, unintended fertility boosts, and the unknown risks these medications pose during pregnancy. Experts now urge dual contraception use and early discontinuation before conception.
